Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Net Income (2017 - 2025)

Historic Net Income for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $21.6 million.

  • Organogenesis Holdings' Net Income rose 7490.07% to $21.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$9.7 million, marking a year-over-year decrease of 3162.6%. This contributed to the annual value of -$9.9 million for FY2024, which is 29935.29% down from last year.
  • Latest data reveals that Organogenesis Holdings reported Net Income of $21.6 million as of Q3 2025, which was up 7490.07% from -$9.4 million recorded in Q2 2025.
  • Organogenesis Holdings' 5-year Net Income high stood at $51.0 million for Q4 2021, and its period low was -$18.8 million during Q1 2025.
  • Moreover, its 5-year median value for Net Income was $3.2 million (2023), whereas its average is $5.2 million.
  • In the last 5 years, Organogenesis Holdings' Net Income skyrocketed by 137302.33% in 2023 and then plummeted by 79728.57% in 2025.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Net Income stood at $51.0 million in 2021, then tumbled by 85.32% to $7.5 million in 2022, then tumbled by 107.59% to -$568000.0 in 2023, then plummeted by 436.27% to -$3.0 million in 2024, then soared by 808.04% to $21.6 million in 2025.
  • Its last three reported values are $21.6 million in Q3 2025, -$9.4 million for Q2 2025, and -$18.8 million during Q1 2025.